ReAlta Life Sciences Presents COPD Treatment at ATS 2025

ReAlta Life Sciences Presents COPD Treatment at ATS 2025

By Karen Roman ReAlta Life Sciences said it presented new clinical data from its Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AE-COPD) program at the American Thoracic Society 2025 International Conference, taking place on May 18-21, in San Francisco. The...

Waldencast Sees Improvement of 10 bps in Adjusted Gross Margin

Waldencast Sees Improvement of 10 bps in Adjusted Gross Margin

By Daniella Parra Waldencast plc (Nasdaq: WALD) said net revenue decreased 4.1% year-over-year to $65.4 million and adjusted gross profit totaled $50.0 million, or 76.4% of net revenue, an expansion of 10 basis points compared to the prior year. Adjusted...

a.k.a. Brands U.S. Net Sales Up 14.2%, Updates FY Guidance

a.k.a. Brands U.S. Net Sales Up 14.2%, Updates FY Guidance

By Karen Roman a.k.a. Brands Holding Corp. (NYSE: AKA) said first quarter net sales grew 10.1% to $128.7 million, compared to $116.8 million the year prior, with U.S. net sales increasing 14.2%. Adjusted EBITDA was $2.7 million, or 2.1% of...

On Q1 Net Sales Increase 43% as DTC Share Surges

On Q1 Net Sales Increase 43% as DTC Share Surges

By Daniella Parra On Holding AG (NYSE: ONON) said net sales increased 43% to CHF 726.6 million as it  increased its direct-to-consumer share, accounting for 38.1% of total net sales. The Swiss-designed running shoe and apparel maker reported a gross...

Input your search keywords and press Enter.